118 related articles for article (PubMed ID: 20574918)
1. Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia.
McCormack E; Skavland J; Mujic M; Bruserud Ø; Gjertsen BT
Nutr Cancer; 2010; 62(5):574-83. PubMed ID: 20574918
[TBL] [Abstract][Full Text] [Related]
2. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
3. Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection.
Kupfahl C; Geginat G; Hof H
Int Immunopharmacol; 2006 Apr; 6(4):686-96. PubMed ID: 16504933
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
5. Modulation of splenic immune responses to bacterial lipopolysaccharide in rainbow trout (Oncorhynchus mykiss) fed lentinan, a beta-glucan from mushroom Lentinula edodes.
Djordjevic B; Skugor S; Jørgensen SM; Overland M; Mydland LT; Krasnov A
Fish Shellfish Immunol; 2009 Feb; 26(2):201-9. PubMed ID: 19010422
[TBL] [Abstract][Full Text] [Related]
6. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
[TBL] [Abstract][Full Text] [Related]
10. Lentinan potentiates immunity and prolongs the survival time of some patients.
Matsuoka H; Seo Y; Wakasugi H; Saito T; Tomoda H
Anticancer Res; 1997; 17(4A):2751-5. PubMed ID: 9252710
[TBL] [Abstract][Full Text] [Related]
11. Protective activity of Lentinan in experimental tuberculosis.
Markova N; Kussovski V; Drandarska I; Nikolaeva S; Georgieva N; Radoucheva T
Int Immunopharmacol; 2003 Oct; 3(10-11):1557-62. PubMed ID: 12946453
[TBL] [Abstract][Full Text] [Related]
12. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
[TBL] [Abstract][Full Text] [Related]
14. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
15. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil treatment of rat leukemia and a reappraisal of its application in human leukemia.
Ermens AA; Kroes AC; Lindemans J; Abels J
Anticancer Res; 1986; 6(4):797-800. PubMed ID: 3752959
[TBL] [Abstract][Full Text] [Related]
18. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
Colly LP; Peters WG; Willemze R
Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
Martens AC; van Bekkum DW; Hagenbeek A
Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
[TBL] [Abstract][Full Text] [Related]
20. [Granulopoietic effects of lentinan in mice: effects on GM-CFC and 5-FU-induced leukopenia].
Matsuo T; Kurahashi Y; Nishida S; Kumada K; Hayami T; Takagi T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1310-4. PubMed ID: 3579329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]